A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis

Clinical trial NCT05223868 · COMPLETED

Trial details

NCT number: NCT05223868
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2022-02-03
Primary completion: 2022-12-15
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.